![Mohamed Wa’el Ahmed Hashad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mohamed Wa’el Ahmed Hashad
Directeur/Membre du Conseil chez
California Life Sciences Association
Fortune : 324 938 $ au 31/05/2026
Profil
Mohamed Wa’el Ahmed Hashad is currently Director at California Life Sciences Association.
Formerly, Mr. Ahmed Hashad was Chief Executive Officer & Director at Longeveron, Inc. from 2023 to 2025, Independent Director at Akari Therapeutics Plc from 2023 to 2024, President & Chief Executive Officer at Avanir Pharmaceuticals, Inc. from 2020 to 2023, Chief Commercial Officer & Executive VP at Seres Therapeutics, Inc. from 2016 to 2017, and Vice President at Amgen, Inc. Education includes an MBA from the University of Akron, undergraduate studies at the University of Cairo, and undergraduate studies at The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/07/2025 | 420 904 ( 1,4% ) | 324 938 $ | 31/05/2026 |
Postes actifs de Mohamed Wa’el Ahmed Hashad
| Sociétés | Poste | Début |
|---|---|---|
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Directeur/Membre du Conseil | - |
Anciens postes connus de Mohamed Wa’el Ahmed Hashad
| Sociétés | Poste | Fin |
|---|---|---|
| LONGEVERON INC. | Directeur Général | 27/08/2025 |
| AKARI THERAPEUTICS, PLC | Directeur/Membre du Conseil | 13/11/2024 |
| AVANIR PHARMACEUTICALS INC | Directeur Général | 01/01/2023 |
| SERES THERAPEUTICS, INC. | Corporate Officer/Principal | 21/06/2017 |
| AMGEN INC. | Corporate Officer/Principal | - |
Formation de Mohamed Wa’el Ahmed Hashad
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
University of Akron
 University of Akron Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cairo
 University of Cairo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Longeveron, Inc.
 Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
